Who invested in Glympse Bio

2 rounds we have observed, with the 12 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$40Mraised across 2 rounds since 2018, from 2 sources

$22MSeries A$18MVenture

Latest round: Venture, $18MDec 2021
Biggest round: $22MSeries A · Oct 2018
Investors: 12

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

201920202021

$22MSeries A$18MVenture

First round: Series A, $22M
Biggest round: $22M
Between rounds: 3.2 years

The rounds

Dec 2021
Venture$18M4 new
Source recordedSEC filing: $18M sold, first sale Dec 2021
Oct 2018
Series A$22M8 new
- GreatPoint Ventures
- Yonghua
- Inevitable Ventures
- Gilead Sciences
- Heritage Provider
- ARCH Ventures/ Charles River
- LS Polaris Innovation Fund
- Rivas
Reported by FinSMEsSEC filing: $26M sold, first sale Jul 2018

Founders and team

From the SEC filings it signed: 6 on the team.

Caroline LoewExecutive Officer, Directori
Dhaval Winckler GosaliaExecutive Officeri
Jessica Winckler AtkinsonExecutive Officeri
Matthew Winckler NavarroExecutive Officeri
Tram Winckler TranExecutive Officeri
Wendy Winckler AdamovichExecutive Officeri

On the board, as filediAmy SchulmanFrancis CussGeorge ZacharyRobert LangerStanley LapidusSteve KafkaTheresia Gouw

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series A2018Venture2021

Alumni Ventures

Temasek Holdings

ARCH Venture Partners

Catalio Capital Management

GreatPoint VenturesYonghua

Inevitable Ventures

Gilead SciencesHeritage ProviderARCH Ventures/ Charles River

Everyone who backed them

Alumni VenturesVC firm1round

Temasek HoldingsVC firm1round

ARCH Venture PartnersVC firm1round

Catalio Capital ManagementVC firm1round

GreatPoint VenturesVC firm1round

YonghuaVC firm1round

Inevitable VenturesVC firm1round

Gilead SciencesCompany1round

Heritage ProviderVC firm1round

ARCH Ventures/ Charles Riverno record of our own yet1round

LS Polaris Innovation Fundno record of our own yet1round

Rivasno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Glympse Bio

Who invested in Glympse Bio?

Glympse Bio's investors include Alumni Ventures, Temasek Holdings, ARCH Venture Partners, Catalio Capital Management and GreatPoint Ventures, and 7 more on record.